DRD1 and adenocarcinoma: Indeed, we found that the DRD1 promoter is significantly hypermethylated in lung cancer using samples from the NCI‐MD cohort (Fig. 1C) and then validated this observation using squamous cell carcinoma and adenocarcinoma data from TCGA (Fig. S2D,E).